The impact of wait times on oncological outcome in high-risk patients with endometrial cancer
- PMID: 32291783
- DOI: 10.1002/jso.25929
The impact of wait times on oncological outcome in high-risk patients with endometrial cancer
Abstract
Objective: To evaluate the impact of surgical wait times on outcome of patients with grade 3 endometrial cancer.
Methods: All consecutive patients surgically treated for grade 3 endometrial cancer between 2007 and 2015 were included. Patients were divided into two groups based on the time interval between endometrial biopsy and surgery: wait time from biopsy to surgery ≤12 weeks (84 days) vs more than 12 weeks. Survival analyses were conducted using log-rank tests and Cox proportional hazards models.
Results: A total of 136 patients with grade 3 endometrial cancer were followed for a median of 5.6 years. Fifty-one women (37.5%) waited more than 12 weeks for surgery. Prolonged surgical wait times were not associated with advanced stage at surgery, positive lymph nodes, increased lymphovascular space invasion, and tumor size (P = .8, P = 1.0, P = .2, P = .9, respectively). In multivariable analysis adjusted for clinical and pathological factors, wait times did not significantly affect disease-specific survival (adjusted hazard ratio [HR]: 1.2, 95% confidence interval [CI], 0.6-2.5, P = .6), overall survival (HR: 1.1, 95% CI, 0.6-2.1, P = .7), or progression-free survival (HR: 0.9, 95% CI, 0.5-1.7, P = .8).
Conclusion: Prolonged surgical wait time for poorly differentiated endometrial cancer seemed to have a limited impact on clinical outcomes compared to biological factors.
Keywords: endometrial cancer; high-grade; hysterectomy; oncological outcome; survival; wait time.
© 2020 Wiley Periodicals, Inc.
References
REFERENCES
-
- Committee CCSA. Canadian Cancer Statistics 2018. Toronto, ON, Canada: Canadian Cancer Society. 2018.
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7-34.
-
- C. K. Cancer of the Corpus Uteri. In SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988-2001, Patient and Tumor Characteristics. NCI, SEER Program; Bethesda, MD: National Cancer Institute, 2007.
-
- Matsuo K, Opper NR, Ciccone MA, et al. Time interval between endometrial biopsy and surgical staging for type I endometrial cancer: association between tumor characteristics and survival outcome. Obstet Gynecol. 2015;125:424-433.
-
- Menczer J, Krissi H, Chetrit A, et al. The effect of diagnosis and treatment delay on prognostic factors and survival in endometrial carcinoma. Am J Obstet Gynecol. 1995;173:774-778.
MeSH terms
LinkOut - more resources
Full Text Sources
